Generic placeholder image



ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Mini-Review Article

A Comparative Study of SARS, MERS with COVID-19

Author(s): Chandra Mohan and Vinod Kumar*

Volume 2, Issue 3, 2021

Published on: 04 September, 2020

Page: [364 - 368] Pages: 5

DOI: 10.2174/2666796701999200905093233


Background: B814, now’s called Coronavirus first identified by Tyrrell and Bynoe in 1965 from the respiratory tract (embryonic tracheal) of an adult and later on during working on National Institutes of Health Robert Chanock used the term “OC” for same virus strain. After several years researchers reported that coronaviruses were caused disease in rats, mice, chickens, turkeys, calves, dogs, cats, rabbits etc. after effecting the enormous variety of animal, in year 2002-2003 it caused new respiratory disease named severe acute respiratory syndrome, (SARS) in southern China.

Objective: The main objective of this article is to compare the status of various previous pandemics (i.e., SARS, MERS) with the current COVID-19 pandemic in terms of the life cycle, diagnosis process and prevention.

Results: On 31st December 2019, the World Health Organization (WHO) office in China received information regarding pneumonia cases of unknown etiology from the Wuhan district in central China. Subsequently, this new disease spread to China, and from there, to the rest of the world. By the end of March 2020, more than 2 million cases were confirmed of this new disease, with over 70000 deaths worldwide. After some time, researchers have identified that this new disease is caused by a novel beta- Coronavirus (virus SARS-CoV-2) and the new disease was named COVID-19. Since then, the Ministry of Health of various countries and WHO have been fighting this health emergency, which has not only affected public health, but also affected various economic sectors.

Conclusion: The current outbreak SARS-CoV-2 phylogenetically resembled to Bat SARS, which was previously identified in year 2002 and 2012 having low mortality rate than MERS and SARS. However, SARS-CoV-2 and MERS having high virological similarity but both use different receptors to take entry in to the host cell via ACE-2 and DPP-4 respectively. Unfortunately, currently there is no approved treatment available worldwide. Currently, we can hope that together we will recover from this public health emergency very soon.

Keywords: Severe Acute Respiratory Syndrome (SARS), Middle East respiratory syndrome coronavirus (MERS-CoV), COVID-19 (SARS CoV-2), life cycle, diagnosis, comparative analysis.

Graphical Abstract
Zhong NS, Zheng BJ, Li YM, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet 2003; 362(9393): 1353-8.
[] [PMID: 14585636]
Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect 2020; 26(6): 729-34.
[] [PMID: 32234451]
Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med 2004; 10(12)(Suppl.): S88-97.
[] [PMID: 15577937]
Dawson P, Malik MR, Parvez F, Morse SS. What have we learned about Middle East Respiratory Syndrome Coronavirus emergence in humans? A systematic literature review. Vector Borne Zoonotic Dis 2019; 19(3): 174-92.
[] [PMID: 30676269]
Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol 2020; 94(7): e00127-20.
[] [PMID: 31996437]
Hashim FA, Mabrouk MS, Atabany WAL. Comparative analysis of DNA motif discovery algorithms: a systemic review. Curr Cancer Ther Rev 2019; 15(1): 4-26.
Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 2015; 1282: 1-23.
[] [PMID: 25720466]
Nikhat S, Fazil M. Overview of Covid-19; its prevention and management in the light of Unani medicine. Sci Total Environ 2020; 728(1): 138859-68.
[] [PMID: 32334163]
Pradeep C, Nandan D, Das AA, Velayutham D. Comparative transcriptome profiling of disruptive technology, single- molecule direct RNA sequencing. Curr Bioinform 2020; 15(20): 165-72.
WHO. World Health Organization, WHO reports on Middle East respiratory syndrome coronavirus (MERS-CoV) 2019.Available from:.
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020; 24: 91-8.
[] [PMID: 32257431]
Chan JW, Lee S. SARS patients and need for treatment. Emerg Infect Dis 2004; 10(10): 1877-8.
[] [PMID: 15515244]
Khalid M, Khan B, Al Rabiah F, et al. Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia. Ann Saudi Med 2014; 34(5): 396-400.
[] [PMID: 25827696]
Vimal KM, Kumar S, Bhatt MLB, Saxena SK. Therapeutic development and drugs for the treatment of COVID-19. Coronavirus Disease 2019 (COVID-19) 2020; 2020: 109-26..
Kim JY, Ko JH, Kim Y, et al. Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea. J Korean Med Sci 2020; 35(7)e86
[] [PMID: 32080991]
Aydin EB, Aydın M, Sezginturk MK. Biosensors in drug discovery and drug analysis. Curr Anal Chem 2019; 15(4): 467-84.
Whitworth J. COVID-19: a fast evolving pandemic. Trans R Soc Trop Med Hyg 2020; 114(4): 241-8.
[] [PMID: 32198918]

© 2024 Bentham Science Publishers | Privacy Policy